• Return to Headlines

After Yesterday's Decline of 3.46%, Halozyme Therape Offers Investors Better Value

By James Quinn

Halozyme Therape (NASDAQ:HALO) traded in a range yesterday that spanned from a low of $22.65 to a high of $25.68. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of $23.11 on volume of 1.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend is tracking the current trend status for Halozyme Therape and will alert subscribers who have HALO in their portfolio or watchlist when shares have changed trend direction.

Halozyme Therape share prices have moved between a 52-week high of $25.68 and a 52-week low of $12.71 and are now trading 89% above that low price at $23.96 per share. The 200-day and 50-day moving averages have moved 0.59% higher and 1.03% higher over the past week, respectively.

Keywords: rebounders halozyme therape

Ticker(s): HALO